President and CEO
Mr. Daniel serves as Chief Executive Officer and President of CCI, primarily responsible for business development, growth and fund-raising needs. His most recent and current business experience is Vice President of Sales and Marketing for Myelotec, Inc., a medical device manufacturing company. Prior to Myelotec, Mr. Daniel was the Vice President of Market Development for Spheringenics, Inc., – a stem cell research company that licensed technology developed at the Georgia Institute of Technology (Georgia Tech). Mr. Daniel also was previously President of Allograft Solutions, Inc., a company that procured, banked and distributed tissue donations.
Tom Barrows, PhD
Executive Vice President and CSO
Dr. Barrows is responsible for operations and research and is the inventor of CCI’s biomaterials technology. His career in biomedical materials research began after obtaining a PhD in organic chemistry from The Pennsylvania State University and includes 22 years at 3M where he invented and developed bioabsorbable polymers and surgical devices including tissue sealants. He was recruited to join a start-up venture in the Boston area in 1996 to continue research on tissue sealants. From there he relocated to Atlanta, GA and co-founded BioAmide, Inc. and began applying tissue engineering principles to the development of solutions for hair restoration, which led to the acquisition of BioAmide in 2002 by Bosley/Aderans (Aderans, Ltd., Tokyo, Japan) and simultaneous formation of the Aderans Research Institute, Inc. (ARI). In 2008 he left ARI and co-founded CCI with the goal of utilizing stem cells to cure chronic wounds.